China on Thursday said it hopes to strengthen communication, enhance mutual trust and build consensus with India and Russia at the annual meeting of the foreign ministers of the three countries at a time when the world has entered a period of turbulence and transformation at a faster pace.
The Russia, India, China (RIC) Foreign Ministers meeting — to be held via video link on Friday — will have in-depth discussion on several issues, including on combating COVID-19, multilateralism, and international and regional hotspots, Chinese Foreign Ministry spokesman Zhao Lijian told a media briefing here. The world is facing the combined impacts of changes unseen in a century and the COVID-19 pandemic, and has entered a period of turbulence and transformation at a faster pace, he said.
As major countries with global influence and the most representative emerging economies, China, Russia and India hold similar positions and shoulder important responsibility in promoting world peace, stability and development, Zhao said. China hopes to strengthen communication, enhance mutual trust and build consensus with Russia and India through this meeting, and send positive messages to the world of practicing real multilateralism, promoting democracy in international relations, fighting the pandemic together, boosting economic recovery and safeguarding world peace and stability, he said.
This is expected to inject more stability and positive energy into the world, Zhao said. India took over the chairmanship of the RIC after the last meeting of RIC Foreign Ministers in Moscow in September 2020. Following the meeting, External Affairs Minister will pass on the chairmanship of the RIC to the Foreign Minister of the People's Republic of China for the next one year, the Ministry of External Affairs said in New Delhi.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.